Detection of IgE binding component to infliximab in a patient with infliximab-induced anaphylaxis

Annals of Allergy, Asthma and Immunology

Volumn 112, Issue 4, 2014, Pages 393-394

  Hwang, Sun Hyuk ^a   Yoo, Hye Soo ^a   Yoon, Moon Kyung ^a   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INFLIXIMAB; PARACETAMOL; STEROID;

ADULT; ANAPHYLAXIS; ANKYLOSING SPONDYLITIS; ANTIBODY DETECTION; BASOPHIL ACTIVATION TEST; BODY TEMPERATURE MEASUREMENT; CASE REPORT; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE FUNCTION TEST; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; INTRACUTANEOUS TEST; LABORATORY TEST; LETTER; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; PREMEDICATION; PRICK TEST; PRIORITY JOURNAL; TACHYPNEA; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE; URTICARIA; WHEEZING;

ADOLESCENT; ADULT; ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; MALE; PROTEIN BINDING; SPONDYLITIS, ANKYLOSING;

EID: 84897445136     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.02.001     Document Type: Article

References (8)

1. R. Maini, E.W. St Clair, and F. Breedveld et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial Lancet 354 1999 1932 1939
2. I. Puxeddu, L. Giori, and V. Rocchi et al. Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab Ann Allergy Asthma Immunol 108 2012 123 124
3. E. Maggi, A. Vultaggio, and A. Matucci Acute infusion reactions induced by monoclonal antibody therapy Expert Rev Clin Immunol 7 2011 55 63
4. M. Benucci, M. Manfredi, G. Saviola, P. Baiardi, and P. Campi Correlation between atopy and hypersensitivity reactions during therapy with three different TNF-α blocking agents in rheumatoid arthritis Clin Exp Rheumatol 27 2009 333 336
5. A. Vultaggio, A. Matucci, F. Nencini, S. Pratesi, and E. Maggi Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction Intern Emerg Med 7 suppl 2 2012 S77 S79
6. A. Vultaggio, A. Matucci, and F. Nencini et al. Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions Allergy 65 2010 657 661
7. L. Manso, B. Polo, M. Fernández-Nieto, L. Sastre, V. del Pozo, and J. Sastre Basophil activation test in a case of systemic hypersensitivity reaction to infliximab with good tolerance to another anti-TNF-alpha agent (adalimumab) J Investig Allergol Clin Immunol 20 2009 537 538
8. S. Kugathasan, M.B. Levy, and K. Saeian et al. Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction Am J Gastroenterol 97 2002 1408 1414